Since 2002, the Partnership for Safe Medicines has been publishing information about the counterfeit drug problem around the world. With experts leading the organization and a committed and passionate set of writers and editors, our content is more in-depth than many other sources, which simply copy links to the news from other websites.
In this editorial by Terry Wilcox published in Inside Sources on April 18, 2019, Terry Wilcox, executive director of a patient advocacy organization advices federal and state representatives that allowing drug importation is not the right policy solution for America’s high prescription drug prices…
In this editorial, which was published in Colorado Politics on April 17, 2019, Don Bell, a 30-year veteran of Canadian law enforcement and border protection, warns that Canadian drug importation will open the U.S. to counterfeit medicine and exacerbate drug shortages in Canada.
In a shocking new report published in the American Journal of Tropical Medicine and Hygiene, researchers have documented the true toll of counterfeit medicines around the world due to medicine being subtherapeutic or outright ineffective. Subtherapeutic medicine allows patients to die without sufficient treatment, but it also creates treatment resistant strains of diseases. The paper…
The editorial board of the The Wall Street Journal published this editorial on April 15, 2019. In it, they write:
“The argument that drug importation threatens the integrity of the drug supply is often dismissed because pharmaceutical lobbyists make it. But keeping the drug supply free from contaminated or counterfeit products is not easy, and the World Health Organization has warned that 1 in 10 medical products in the developing world are phony. It isn’t clear who is liable if counterfeits are found in Florida, but you can bet it won’t be the politicians.”
April 12, 2019 (Tallahassee, FL) — Importation undermines our core efforts to keep our medicine supply safe. State and federal authorities regulate every entity in the U.S. supply chain from the point of manufacture until a medicine is dispensed, and that makes counterfeits in the legitimate supply chain rare. In 2013, Congress passed the Drug…
In March 2019, the U.S. Food and Drug Administration issued warning letters to a website and an online pharmacy network for selling misbranded mifepristone and misoprostol
In this editorial, which was published in The Gadsden Times on April 11, 2019, former FDA-OCI director George Karavetsos points out the real dangers of drug importation:
“Even today, Americans are being hurt and even dying because of counterfeit medications being imported into this country. Adding insult to injury, while some might point to Canada as being a safe source, counterfeit medications are transshipped through Canada from other countries in remote corners of the globe.”
The News and Record has reported about a North Carolina resident, Yazid Al Fayyad Finn, who was arrested in 2018 for his part in a plot to steal a 200 pound shipment of counterfeit Xanax that was being smuggled across the Quebec-Vermont border.
WASHINGTON (April 8, 2019) – As members of Congress and leaders in the executive branch consider steps to allow wholesale importation of prescription medications, organizations representing consumers, employers, healthcare professionals, patients, and law enforcement officers, among others, are insisting that such proposals, if implemented, would endanger the health and safety of the communities throughout the country…
On March 15th, two different busts in Arizona highlighted the problems the Grand Canyon State is having with counterfeit pills.